329 related articles for article (PubMed ID: 14663596)
1. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
Horstkotte D; Mellwig KP
Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
3. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
4. [H.E.L.P. apheresis and oxidative stress].
Pulawski E; Mellwig KP; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
[TBL] [Abstract][Full Text] [Related]
5. [Clinical long-term results of H.E.L.P.-apheresis].
Schuff-Werner P
Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
[TBL] [Abstract][Full Text] [Related]
6. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced extracorporeal low-density lipoprotein precipitation.
Mellwig KP
Ther Apher Dial; 2003 Jun; 7(3):365-9. PubMed ID: 12924614
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial].
Suckfüll M; Seidel D; Thiery J; Mazurek B; Jaehne M; Gronemeyer J; Reichel O; Sasama J; Kichigina S; Möller M; Beil FU; Schrameyer-Wernecke A; Kassner U; Koch M; Jaeger B; Osterkorn K; Osterkorn D
Z Kardiol; 2003; 92(Suppl 3):III59-63. PubMed ID: 14663604
[TBL] [Abstract][Full Text] [Related]
9. Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia.
Jaeger BR; Tsobanelis T; Bengel F; Schwaiger M; Seidel D
J Pediatr; 2002 Jul; 141(1):125-8. PubMed ID: 12091863
[TBL] [Abstract][Full Text] [Related]
10. Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease.
Blessing F; Wang Y; Walli AK; Seidel D
Transfus Apher Sci; 2004 Jun; 30(3):255-66. PubMed ID: 15172631
[TBL] [Abstract][Full Text] [Related]
11. [LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis].
Sattler AM; Bock K; Schmidt S; Maisch B; Schaefer JR
Z Kardiol; 2003; 92(Suppl 3):III64-7. PubMed ID: 14663605
[TBL] [Abstract][Full Text] [Related]
12. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
[TBL] [Abstract][Full Text] [Related]
13. Shear stress-dependent platelet function after LDL cholesterol apheresis.
Spieker LE; Ruschitzka F; Badimon JJ; Noll G; Corti R
Thromb Res; 2004; 113(6):395-8. PubMed ID: 15226094
[TBL] [Abstract][Full Text] [Related]
14. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness].
Walch C; Anderhuber W; Walzl M
Laryngorhinootologie; 1996 Nov; 75(11):641-5. PubMed ID: 9063830
[TBL] [Abstract][Full Text] [Related]
15. [Lipoprotein(a): Aspects of pathophysiology, epidemiology and treatment].
Thomas HP; Steinhagen-Thiessen E
Z Kardiol; 2003; 92(Suppl 3):III53-8. PubMed ID: 14663603
[TBL] [Abstract][Full Text] [Related]
16. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
Suckfüll M
Ther Apher; 2001 Oct; 5(5):377-83. PubMed ID: 11778923
[TBL] [Abstract][Full Text] [Related]
17. Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?
Ramunni A; Quaranta N; Saliani MT; Fallacara RA; Ria R; Ranieri G
Ther Apher Dial; 2006 Jun; 10(3):282-6. PubMed ID: 16817795
[TBL] [Abstract][Full Text] [Related]
18. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
Mo JK; Li YX; Lei D; Wu DH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791
[TBL] [Abstract][Full Text] [Related]
19. Lipid apheresis: oxidative stress, rheology, and vasodilatation.
Mellwig KP; Pulawski E; Horstkotte D; van Buuren F
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):45-9. PubMed ID: 22528131
[TBL] [Abstract][Full Text] [Related]
20. Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment.
Mellwig KP; van Buuren F; Schmidt HK; Wielepp P; Burchert W; Horstkotte D
Ther Apher Dial; 2006 Dec; 10(6):510-7. PubMed ID: 17199883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
